Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,257 total articles
Immix Biopharma, a Nasdaq-listed biotechnology company specializing in AL Amyloidosis, announced the closing of a $150 million underwritten offering of common stock, raising net proceeds of approximately $140.65 million. The capital raise involved prominent U.S. biotechnology institutional investors and mutual funds and will support the ongoing cli…
LGI Homes announces the grand opening of Allen Townhomes, a 36-lot community in Arlington, Washington, designed with contemporary features and flexible floor plans. The company offers its CompleteHome Plus package at an affordable price with incentives such as interest rate buy downs and builder closing cost contributions, targeting strong demand f…
Atlantic American Corporation announced that it received a Nasdaq notice due to failure to timely file its Quarterly Report on Form 10-Q for Q1 2026 and its Annual Report on Form 10-K for 2025. The company must submit a plan to regain compliance by June 16, 2026, or face potential consequences. Atlantic American is an insurance holding company invo…
Alerus Financial Corporation declared a quarterly cash dividend of $0.22 per common share, marking a 4.76% increase from last year. This dividend payment underscores the company's strong financial performance and commitment to returning value to shareholders. The dividend will be payable on July 10, 2026, to shareholders of record as of June 26, 20…
Greenwich LifeSciences, a clinical-stage biopharmaceutical company focused on immunotherapy for breast cancer recurrence prevention, announced it received a Nasdaq notification due to a delay in filing its Quarterly Report on Form 10-Q for Q1 2026. While trading continues uninterrupted, the notice indicates non-compliance with Nasdaq listing rules …
Apogee Acquisition Corp announced that from May 28, 2026, holders of its IPO units may elect to separately trade Class A ordinary shares, warrants, and rights on Nasdaq under symbols AACP, AACPW, and AACPR, respectively. The company, a special purpose acquisition company (SPAC), focuses on acquiring technology-related businesses. Units not separate…
Empro Group Inc., a Malaysia-based beauty and personal care company listed on Nasdaq, announced it received a notification from Nasdaq concerning non-compliance with listing rules due to the delayed filing of its annual Form 20-F for fiscal year 2025. The company has 60 days to submit a plan to regain compliance and potentially up to 180 additional…
Nanobiotix, a late-stage clinical biotechnology company, announced the full exercise of underwriters' over-allotment option in its global offering, resulting in gross proceeds of approximately $100 million. The proceeds will primarily fund the advancement of its Nanoprimer platform and other technologies, as well as support development of JNJ-1900 …
ACP Holdings Acquisition Corp., a US-listed blank check company focused on private credit investments, announced that its Class A ordinary shares and warrants will begin separate trading on Nasdaq around May 28, 2026. Holders of units sold in the IPO may elect to separate their units into individual shares and warrants. The company is seeking a bus…
SCYNEXIS, Inc., a clinical-stage biotechnology company, announced a one-for-eight reverse stock split effective May 29, 2026, to comply with Nasdaq's minimum bid price requirements. The reverse split will reduce the shares outstanding from approximately 79.5 million to 9.9 million, with no change to the company's market capitalization. The split-ad…
Terra Innovatum Global N.V. (NASDAQ: NKLR) announced a delay in filing its annual Form 10-K for fiscal year 2025, now expected by June 15, 2026, due to complex post-merger accounting and multi-jurisdictional reporting requirements. The Company also received a Nasdaq Listing Delinquency Letter but is working to regain compliance. The quarterly Form …
Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) has announced a tender offer to repurchase up to 10% of its outstanding shares at 98% of NAV and has approved an 8% increase in its monthly distribution under its Level Distribution Plan. The tender offer will run from June 1 to July 1, 2026, and the monthly distribution increase results in a 9% y…
Mission Produce and Calavo Growers announced that Mission Produce has received antitrust clearance from Mexico's Federal Economic Competition Commission, fulfilling a key closing condition for its pending acquisition of Calavo. The companies expect the transaction to close on May 28, 2026, subject to remaining conditions. Both companies operate glo…
Orange County Bancorp, Inc., the parent company of Orange Bank & Trust Company and Orange Investment Advisors, announced a cash dividend of $0.18 per share, payable on June 15, 2026 to shareholders of record as of June 4, 2026. This reflects the company's commitment to returning value to its shareholders amid its growth to $2.6 billion in assets.
XTL Biopharmaceuticals Ltd. has received a formal notice from Nasdaq's Listing Qualifications Department indicating potential delisting from the Nasdaq Capital Market due to failure to timely file its Annual Report on Form 20-F for 2025, along with previously disclosed deficiencies involving minimum stockholders’ equity and bid price requirements. …
Maris-Tech Ltd. announced it received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement of $2.5 million, reporting equity of approximately $601,583 as of December 31, 2025. The company has until July 6, 2026 to submit a plan to regain compliance and may receive an extension if the plan is accepte…
Abivax SA disclosed its Q1 2026 financial results alongside promising three-year interim data from Study 108, a Phase 2a/2b open-label extension trial of obefazimod in moderately to severely active ulcerative colitis (UC) patients. The study shows durable clinical remission rates of 68% after dose de-escalation to 25 mg over 144 weeks, with no new …
E-Power Inc., a Nasdaq-listed company specializing in graphite anode materials for lithium-ion batteries, announced it received a notification from Nasdaq indicating its stock price has fallen below the minimum bid price requirement of $1.00 for 30 consecutive business days. The company has until November 16, 2026, to regain compliance by maintaini…
Crinetics Pharmaceuticals announced its participation in the Jefferies Global Healthcare Conference in June 2026, where management will hold one-on-one meetings with investors. The company specializes in endocrine disease treatments, with an FDA-approved product and multiple drug candidates in development targeting endocrine and oncology-related di…
Dynagas LNG Partners LP, an owner of LNG carriers, will release its financial results for the first quarter ended March 31, 2026, on May 29, 2026, ahead of the market open in New York, along with an accompanying slide presentation available on its website.
Avalo Therapeutics, a clinical stage biotechnology company, announced an inducement award of stock options to a new employee, approved under Nasdaq Listing Rule 5635(c)(4). The options grant 34,000 shares at an exercise price equal to the closing stock price of $16.60 per share, with a multi-year vesting schedule.
All In FutureTech Alliance Inc. (Nasdaq: AGAE) announced its strategic direction following the acquisition of a controlling interest in HyalRoute Fiber-Optic Communication Group, a company owning extensive fiber-optic networks in Southeast Asia and submarine cable assets. The acquisition marks a key milestone in AIFA's transformation from an experi…
Pharming Group has secured European Commission marketing authorization for Joenja® (leniolisib), the first approved treatment for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in the EU. This approval expands the drug's global reach, already approved in the US, UK, Japan, Australia, and Israel, with planned European launch start…
Scilex Holding Company, a Nasdaq-listed biopharmaceutical firm specializing in non-opioid pain management products, declared a dividend distribution of Semnur Pharmaceuticals, Inc. common stock to its eligible shareholders as of June 1, 2026. This dividend correlates to one share of Semnur for each Scilex common share held. The move reflects Scilex…
VS Media Holdings Limited announces its strategic entry into the AI Smart Living sector, aiming to leverage its existing digital media and creator network strengths to explore growth in smart living products and services. The company plans to develop an international business platform, establish partnerships, and gradually commercialize offerings i…
